Effectiveness of an Innovative Program in Primary Care for Vulnerable and Precarious Population With Access Barriers to Healthcare System: PASS de Ville

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04321824

Acronym

EFFIPASS

Enrollment

488

Registered

2020-03-25

Start date

2020-05-01

Completion date

2023-11-01

Last updated

2020-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vulnerable and Precarious Poupulation

Brief summary

Since the end of 2018, the Care and Orientation Center (CASO)of Marseille corridnated by Medecins du Monde has been investigated an innovative program aimed at direct referrals to primary care for vulnerable and precarious population with access barriers to healthcare system (no being coveraged at time of the study). Patients consulting at the CASO MDM in Marseille are accompanied and were received, free of charge, by primary care professionals (general practitioners, specialists, pharmacy, analysis laboratory, etc). This is an observational, comparative study, with two arms: the CASO MDM in Marseille for the intervention site and the CASO MDM in Bordeaux for the control site (where the innovative program does not exist). A total of 610 patients will be included (305 in the innovative group / 305 in the control group). The main objective is to evaluate the effectiveness of the innovative programm (PASS de ville) compared to the standard of care by assessing the rate of emergency departement visits at one year in each group. Duration of inclusion: 12 months; Duration of follow-up: 18 months; Total duration of the study: 36 months. Both quantitative and qualitative analyses will be conducted to address overall outcomes. Univariate and multivariate analyzes will be performed on the primary outcome as well as the secondary outcomes in order to highlight significant differences between the two groups and to identify predictive factors for improved effectiveness. The analysis will be conducted in accordance with Good Epidemiological Practices, and the final report will be written according to the CONSORT (Consolidated Standards of Reporting Trials) recommendations. An intention to treat analysis will be conducted.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* at least 18 years old * without health coverage * having medical needs * not presenting a vital emergency * not requiring hospital technical platform * having declared to want to stay in the area at least 18 months afetr inclusion in the study * having signed the notice of non opposition to the study

Exclusion criteria

* less than 18 years old * having effective health coverage * in a life-saving emergency * needing access to the hospital technical platform * presenting cognitive impairment that limits comprehension

Design outcomes

Primary

Measure	Time frame
rate of emergency departement visits	12 months

Secondary

Measure	Time frame	Description
Mean change from baseline in Quality of life scores on the WHOQOL	18 months	WHOQOL scale

Countries

France

Contacts

Primary ContactPascal AUQUIER

pascal.auquier@univ-amu.fr33(0)4 91 38 47 44

Outcome results